{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:05:48Z","timestamp":1792782348540,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"British Heart Foundation Centre of Research Excellence","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"https:\/\/ror.org\/02wdwnk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Vera Melrose"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Although the prevalence of heart failure (HF) increases markedly with advancing age, surprisingly little is known about HF in the very elderly. The aim of this study was to describe the clinical characteristics and outcomes of octogenarians with HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Individual participant meta-analysis of patients with HF and reduced, mildly reduced, and preserved ejection fraction (HFrEF, HFmrEF, and HFpEF, respectively) enrolled in eight large randomized trials. Overall, the proportion of octogenarians was 1518 of 20\u2009168 patients (7.5%) with HFrEF, 610 of 4609 (13.2%) with HFmrEF, and 3130 of 15\u2009354 (20.4%) with HFpEF. Regardless of HF phenotype, octogenarian patients were more often female and had more comorbidities, more symptoms and signs of congestion, and worse health status (but not quality of life), in comparison to patients aged &amp;lt;80\u2009years. The incidence (per 100 person-years) of the composite of cardiovascular death or HF hospitalization was 13.3 (95% confidence interval [CI] 12.7\u201314.0) in octogenarians versus 9.5 (95% CI 9.3\u20139.7) in non-octogenarians (adjusted hazard ratio [aHR] 1.40, 95% CI 1.32\u20131.48). Each component of the composite was more frequent in octogenarians with rates of cardiovascular mortality of 7.0 (95% CI 6.5\u20137.4) per 100 person-years versus 4.9 (95% CI 4.8\u20135.1) in non-octogenarians (aHR 1.60, 95% CI 1.48\u20131.72, p\u2009&amp;lt;\u20090.001). Octogenarians received less evidence-based therapy, especially mineralocorticoid receptor antagonists, than younger patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite worse health status and higher hospitalization and mortality rates, octogenarians were undertreated compared to younger patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3417","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:20:20Z","timestamp":1724286020000},"page":"1403-1417","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Characteristics and Outcomes of Patients Aged 80\u2009Years and Over with Heart Failure: Need for Better Treatment"],"prefix":"10.1093","volume":"27","author":[{"given":"Mingming","family":"Yang","sequence":"first","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder S.","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Minnesota , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus Medical Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Campbell","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore & Duke-National University of Singapore , Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"ANMCO Research Center, Heart Care Foundation , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Universidad Nacional of C\u00f3rdoba , C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"O'Meara","sequence":"additional","affiliation":[{"name":"Montreal Heart Institute Department of Medicine (Cardiology) and Research Centre, Universit\u00e9 de Montr\u00e9al , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute, Baylor University Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[{"name":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Kerr Saraiva","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Instituto de Pesquisa Cl\u00ednica de Campinas , Campinas ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Inserm CIC 1433 and Universit\u00e9 de Lorraine, Centre Hospitalier R\u00e9gional Universitaire , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[{"name":"RHJ Department of Veterans Affairs Medical Center, Medical University of South Carolina , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"2026021721465196800_ejhf3417-bib-0001"},{"key":"2026021721465196800_ejhf3417-bib-0002","volume-title":"Health at a Glance 2017","author":"Organisation for Economic Cooperation and Development (OECD)"},{"key":"2026021721465196800_ejhf3417-bib-0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"key":"2026021721465196800_ejhf3417-bib-0004","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0006","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2008","journal-title":"Eur Heart J"},{"key":"2026021721465196800_ejhf3417-bib-0007","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00392-020-01607-y","article-title":"Medical treatment of octogenarians with chronic heart failure: Data from CHECK-HF","volume":"109","author":"Linssen","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2026021721465196800_ejhf3417-bib-0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00228-014-1794-7","article-title":"Heart failure prognosis and management in over-80-year-old patients: Data from a French national observational retrospective cohort","volume":"71","author":"Vorilhon","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"2026021721465196800_ejhf3417-bib-0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ggi.14558","article-title":"Differences in clinical outcomes between octogenarian and nonagenarian patients with acute heart failure","volume":"23","author":"Sakaguchi","year":"2023","journal-title":"Geriatr Gerontol Int"},{"key":"2026021721465196800_ejhf3417-bib-0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020501","article-title":"Management and prognosis of heart failure in octogenarians: Final report from the KorAHF registry","volume":"9","author":"Oh","year":"2020","journal-title":"J Clin Med"},{"key":"2026021721465196800_ejhf3417-bib-0011","first-page":"883","article-title":"Temporal trends in characteristics, treatment, and outcomes of heart failure in octogenarians over two decades","volume":"75","author":"De Maria","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026021721465196800_ejhf3417-bib-0012","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","article-title":"Aliskiren, enalapril, or aliskiren and enalapril in heart failure","volume":"374","author":"McMurray","year":"2016","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0013","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0014","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"key":"2026021721465196800_ejhf3417-bib-0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"2026021721465196800_ejhf3417-bib-0016","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cardfail.2005.06.432","article-title":"The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design","volume":"11","author":"Carson","year":"2005","journal-title":"J Card Fail"},{"key":"2026021721465196800_ejhf3417-bib-0017","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0018","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/oxfordjournals.aje.a009966","article-title":"Application of the missing-indicator method in matched case-control studies with incomplete data","volume":"150","author":"Huberman","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2026021721465196800_ejhf3417-bib-0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0020","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"2026021721465196800_ejhf3417-bib-0021","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021721465196800_ejhf3417-bib-0022","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9610(80)90246-9","article-title":"Prognostic nutritional index in gastrointestinal surgery","volume":"139","author":"Buzby","year":"1980","journal-title":"Am J Surg"},{"key":"2026021721465196800_ejhf3417-bib-0023","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"key":"2026021721465196800_ejhf3417-bib-0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2009.04.011","article-title":"Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: Results from the Italian Survey on Acute Heart Failure","volume":"158","author":"Miani","year":"2009","journal-title":"Am Heart J"},{"key":"2026021721465196800_ejhf3417-bib-0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","article-title":"Prevalence of chronic heart failure in southwestern Europe: The EPICA study","volume":"4","author":"Ceia","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026021721465196800_ejhf3417-bib-0026","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13341","article-title":"Clinical features of heart failure with mid-range and preserved ejection fraction in octogenarians: Results of a multicentre, observational study","volume":"73","author":"\u00d6zlek","year":"2019","journal-title":"Int J Clin Pract"},{"key":"2026021721465196800_ejhf3417-bib-0027","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1532-5415.2010.03145.x","article-title":"Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: The Concord Health and Ageing in Men Project","volume":"58","author":"Hairi","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"2026021721465196800_ejhf3417-bib-0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1152\/jappl.1981.51.3.762","article-title":"Total plasma creatinine: An accurate measure of total striated muscle mass","volume":"51","author":"Schutte","year":"1981","journal-title":"J Appl Physiol"},{"key":"2026021721465196800_ejhf3417-bib-0029","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","article-title":"Domain management approach to heart failure in the geriatric patient: Present and future","volume":"71","author":"Gorodeski","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026021721465196800_ejhf3417-bib-0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ehjcvp\/pvad036","article-title":"Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction","volume":"9","author":"Stolfo","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026021721465196800_ejhf3417-bib-0031","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.2928","article-title":"Association between a hospitalization for heart failure and the initiation\/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry","volume":"25","author":"Schrage","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021721465196800_ejhf3417-bib-0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cjco.2023.01.002","article-title":"Use of guideline-directed medical therapy in patients aged 80\u2009years or older with heart failure with reduced ejection fraction","volume":"5","author":"Barry","year":"2023","journal-title":"CJC Open"},{"key":"2026021721465196800_ejhf3417-bib-0033","first-page":"6","article-title":"Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives","volume":"3","author":"Vizzardi","year":"2014","journal-title":"Int J Cardiol Heart Vessel"},{"key":"2026021721465196800_ejhf3417-bib-0034","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamacardio.2022.3736","article-title":"Effect of dapagliflozin on cause-specific mortality in patients with heart failure across the spectrum of ejection fraction: A participant-level pooled analysis of DAPA-HF and DELIVER","volume":"7","author":"Desai","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026021721465196800_ejhf3417-bib-0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0036","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021721465196800_ejhf3417-bib-0037","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/ejhf.2722","article-title":"Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril\/valsartan","volume":"24","author":"Yang","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021721465196800_ejhf3417-bib-0038","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jchf.2020.11.009","article-title":"Dapagliflozin in HFrEF patients treated with mineralocorticoid receptor antagonists: An analysis of DAPA-HF","volume":"9","author":"Shen","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026021721465196800_ejhf3417-bib-0039","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.122.061754","article-title":"Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: A prespecified analysis of the DELIVER trial","volume":"146","author":"Butt","year":"2022","journal-title":"Circulation"},{"key":"2026021721465196800_ejhf3417-bib-0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/M21-4776","article-title":"Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: A post hoc analysis of the DAPA-HF trial","volume":"175","author":"Butt","year":"2022","journal-title":"Ann Intern Med"},{"key":"2026021721465196800_ejhf3417-bib-0041","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ageing\/afm078","article-title":"Four years on: The impact of the National Service Framework for Older People on the experiences, expectations and views of older people","volume":"36","author":"Manthorpe","year":"2007","journal-title":"Age Ageing"},{"key":"2026021721465196800_ejhf3417-bib-0042","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/ageing\/afab136","article-title":"Perspectives on ageing: A qualitative study of the expectations, priorities, needs and values of older people from two Canadian provinces","volume":"50","author":"Savage","year":"2021","journal-title":"Age Ageing"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/8\/1403\/66813474\/eurjhf_27_8_1403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/8\/1403\/66813474\/eurjhf_27_8_1403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:47:02Z","timestamp":1771382822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/8\/1403\/8468107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,21]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3417","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"2024-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}